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Abstract
Cerebral autoregulation refers to regulation mechanisms that aim to maintain cere-
bral blood flow approximately constant. It is often assessed by autoregulation index
(ARI), which uses arterial blood pressure and cerebral blood flow velocity time series
to produce a ten-scale index of autoregulation performance (0 denoting the absence of
and 9 the strongest autoregulation). Unfortunately, data are rarely free from various
artefacts. Here, we consider four of the most common non-physiological blood pres-
sure artefacts (saturation, square wave, reduced pulse pressure and impulse) and study
their effects on ARI for a range of different artefact sizes. We show that a sufficiently
large saturation and square wave always result in ARI reaching the maximum value of
9. The pulse pressure reduction and impulse artefact lead to a more diverse behaviour.
Finally, we characterized the critical size of artefacts, defined as the minimum artefact
size that, on average, leads to a 10% deviation of ARI.
Keywords: cerebral autoregulation, cerebral blood flow, arterial blood pressure,
blood pressure artefacts
1 Introduction
Cerebral autoregulation (CA) encompasses all the cerebral blood flow regulation mecha-
nisms that maintain cerebral blood flow at an approximately constant level despite changes
in arterial blood pressure (ABP). The importance of CA is highlighted by a connection
between CA impairment and clinical disorders such as stroke [2], subarachnoid hemorrhage
[5] and head injury [1].
Many different data-driven and physiologically-based approaches have been proposed
to assess CA [11, 10, 8]. Cerebral autoregulation index (ARI), proposed in 1995 by Tiecks
et al. [12], is one of the most popular methods currently used. Given an ABP time series it
employs a system of difference equations to predict cerebral blood flow velocity (CBFV),
from which a ten-point (0-9) grading index is calculated (0 represents the absence of, and
9 the best autoregulation).
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The reliability of studies involving CA depends heavily on a number of factors including
the accuracy of the CA assessment method and the quality of time series data. However,
the clinical signals are rarely free from various artefacts and the impact on ARI estimates is
poorly understood. Previously, Li et al. [6] used a large number of time series to identify
the most common non-physiological ABP artefacts. Building on this classification, we
consider four artefacts (saturation, square wave, pulse pressure reduction and impulse)
of different magnitudes and embed them in the ABP time series (size 0 corresponds to
unperturbed ABP and size 20 corresponds to ABP with the maximum perturbation).
Within this framework, we study what effects each of the four artefacts separately can
have on ARI. Among other things, we determine the critical artefact, defined here as the
size of an artefact that results in an ARI change of 10% compared to the unperturbed
data.
2 Methods
2.1 Data collection and preprocessing
Thirty-six, approximately one-minute, baseline (steady state) ABP and CBFV time series
from healthy normotensive subjects are used in the current study. The data collection pro-
tocol have previously been discussed in detail in [7]. The time series were low-pass filtered
using zero-phase 4th-order Butterworth filter, in both directions, with a cutoff frequency
of 20Hz. The beat-to-beat average of ABP and CBFV were calculated for each detected
cardiac cycle. The time series were interpolated using a first-order polynomial and subse-
quently downsampled at 10Hz to produce signals with a uniform time base. Preprocessed
ABP and CBFV time series are denoted by P [k] and V [k] and the corresponding mean
time series by P¯ and V¯ , respectively.
2.2 ARI
The computation of ARI follows the original formulation by Tiecks et al. [12]. The
pressure P [k] is initially normalized:
dP [k] =
P [k]− P¯
P¯ − Pcr
, (1)
where Pcr = 12mmHg is the critical closing pressure. The method uses a difference model
to predict V [k] as follows:
x1[k] = x1[k − 1] +
dP [k]− x2[k − 1]
fT
x2[k] = x2[k − 1] +
x1[k − 1]− 2Dx2[k − 1]
fT
Vˆ [k] = V¯ (1 + dP [k]−Kx2[k]),
(2)
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where f is the sampling frequency. The three parameters T,D and K are the damping
factor, time constant and a parameter reflecting autoregulatory gain, respectively. Com-
binations of ten different values of (T,D,K), see [12], are used to generate ten model
responses of CBFV, denoted Vˆj[k], corresponding to various grades of autoregulation,
ranging from 0 (absence of autoregulation) to 9 (strongest autoregulation). The difference
between the predicted and measured CBFV is computed as dj = ‖(Vˆj [k]−V [k])/V¯ ‖, where
‖ · ‖ is the l2-norm. The ARI is computed as
ARI = arg min
s∈{0,...9}
fARI(s), (3)
where fARI(s) is the interpolation by cubic splines of the values dj .
2.3 Non-physiological blood pressure artefacts
Here we describe the four common blood pressure artefacts used in the current study,
which largely follows the classification given in Li et al. [6].
Saturation to ABP maximum (Amax). This artefact is observed as a quick saturation
of ABP to some maximum value and it is modelled as
Amax(α,L, Pmax) = tanh (αpi t) (Pmax − Pdias) + Pdias, t ∈ [0, L], (4)
where t is the time of the current value of the artefact and Pdias is the diastolic blood
pressure. The three parameters that govern the shape of the artefact (and their range)
are the saturation rate α ∈ [0, 0.1] to the maximal value Pmax ∈ [190, 210] mmHg and the
length of the duration L ∈ [0, 5] s.
Square wave (Asw). We assume the square wave artefact is symmetric; the first half
being set at maximal blood pressure value and the second half of the square wave at zero.
It can be modelled as:
Asw(Pmax, L) =
{
Pmax t ∈ [0, L/2]
0 t ∈ [L/2, L].
(5)
The shape of the square wave is governed by two paramters: the maximal blood pressure
value Pmax ∈ [190, 210] mmHg and the length of the artefact duration L ∈ [0, 10] s.
Pulse pressure reduction (App). This artefact appears as a gradual decrease in pulse
pressure over time and is usually caused by a thrombus in the arterial line. We simulate
the artefact by decreasing the systolic blood pressure linearly over a 45-second window.
The slope of the decay is governed by the ratio at the end of the artefact, from 1 (no
artifact) to 0.1.
Impulse (Aimp). Impulse artefacts appear as a rapid increase in pulse pressure which
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may last from one to several blood pressure pulses. These are generally caused by motion
or mechanical artefacts like crimping of the tube. To model it we define the central lobe
of the normalized sinc function
fL =


L sin(2pit/L)
2pit
t ∈ [−L/2, L/2]
0 otherwise.
Note that fL is continuous and fL = 1 at t = 0 and parameter L is the width of the
normalized central lobe of the sinc function. The impulse artefact can now be simulated
by superimposing a scaled fL on the blood pressure
Aimp(L) = P + (Psys − Pdia) fL, t ∈ [−L/2, L/2], (6)
where Psys and Pdia are the systolic and diastolic pressure, respectively.
3 Results
3.1 Data characterization
Table 1 (level 0) gives the mean and standard deviation for the unperturbed (artefact
free) ABP signal. The standard deviation is understood here as the mean of the standard
deviations within each subject along time.
3.2 Effects of artefacts on ABP
Figure 1 illustrates each of the four non-physiological artefacts, of size 10 and 20, in-
corporated into the raw ABP signal, 5 seconds from the beginning of the time series.
Table 1 (level 10 and 20) shows the corresponding changes in the mean ABP and stan-
dard deviation. Since the artefacts are non-physiological, they do not affect the CBFV
measurements, so there is no difference in the mean CBFV despite increases in artefact
levels.
3.3 Effects of artefacts on ARI
Figure 2 shows the ARI trajectory calculated for all subjects (left panel) and mean ARI
and standard deviation (right panel), denoted mARI± SD, in response to various artefact
levels. In the case of saturation and square artefacts, a sufficiently strong perturbation
of the signal always results in ARI saturating to the maximum value for all subjects.
Additionally, for the square artefact, the ARI dips to almost zero before reaching the
maximum value of 9. The ARI response to the pulse pressure reduction and impulse
artefacts, on the other hand, show more moderate changes in the mean ARI.
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3.4 Critical artefact level size
Table 2 shows the mean and standard deviation of the critical artefacts, i.e. those for
which the ARI differs from the initial estimation by 10%. Since artefact size is measured
somewhat arbitrarily, we also include the corresponding artefacts’s parameters (defined in
Section 2.3). We discard the subjects for which the ARI never changes more than 10%.
4 Discussion
Only a few studies have considered the effects of physiological and non-physiological arte-
facts on cerebral blood flow regulation, mainly in the context of the transfer function. In
[4] the authors studied the influence of ectopic heart beats, which are naturally occurring
episodes. They cause spikes in both the mean ABP and CBFV and can be viewed as a
type of physiological artefact. The study showed that replacing ectopic beats by linear
interpolation reduced the gain and coherence of the transfer function across the frequency
bands. In [3] the authors studied the effects of signal loss in both ABP and CBFV. Their
results seem to indicate that the estimates become unreliable with more than 5 seconds
of data loss every 50 seconds. Recently in [9] the authors investigated the role of three
types of artefacts on transfer function: loss of signal, motion artefacts and baseline drifts.
Among other things, the study showed that the CA estimates become unreliable when
approximately 10% of ABP or 8% of CBFV is lost.
Our results show that although the four artefacts under consideration strongly affect
the ARI values, there were important qualitative differences between them. We note that
for a sufficiently large size of the saturation and square wave, ARI always resulted in
the maximum value of 9. However, pulse pressure reduction and impulse exerted a more
diverse influence. For example, for larger size (around 12 and greater) artefacts the ARI
tends to shift upward, but this behaviour is not uniform across individuals.
The results related to critical artefact, given in Table 2, corroborate those in Figure 2.
Although the critical value is similar for the maximal saturation and the impulse artefact
we note that the latter has a larger standard deviation. There are several potential appli-
cations of the critical artefacts. They can be thought of as a signal quality index to flag
up the ARI estimates that are unreliable. Similarly, it can be used in the preprocessing
phase to mark the artefacts that must be removed from the signal.
The current study has several limitations. The approximation of cerebral blood flow
by CBFV measured in the MCA is only valid if the diameter of the MCA is constant.
Although currently there are no rigorous studies showing what is the minimal length
needed for the reliable estimation of autoregulation indices, the short time series used in
the current study (approximately of 1 minute) might introduce an additional bias to the
results.
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Figure 1: Non-physiological blood pressure artefacts. The four non-physiological
artefacts of size 10 and 20 commonly occurring during ABP measurements.
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Figure 2: Effects of artefacts on ARI. Left panel: The ARI calculated for all normoten-
sive subjects in response to four different types of artefacts. Right panel: The mean ARI
± SD in response to four different levels of artefacts. The size of the artefact are graded
on the scale from 0-20
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Tables
Level 0 Level 10 Level 20
Artefact Quantity Units Mean SD Mean SD Mean SD
Amax ABP mmHg 88.43 11.28 91.29 10.92 96.07 10.66
Asw ABP mmHg 88.43 11.28 88.20 11.64 86.16 10.28
App ABP mmHg 88.43 11.28 85.28 11.00 82.13 10.76
Aimp ABP mmHg 88.43 11.28 88.71 11.30 90.00 11.41
All CBFV cm/s 42.73 12.21 42.72 12.20 42.74 12.20
Table 1: The main characteristics of the beat-to-beat average ABP and CBFV. The ‘Mean’
is the calculated as the mean across all subjects. Note that Level 0 correspond to the data
free from artefacts.
Artefact Critical size Parameters
Amax 5.21 ± 2.1 L=1.3 s Pmax = 195.2mmHg α = 0.026
Asw 2.75 ± 2.1 L=1.4 s Pmax = 192.8mmHg
App 8.06 ± 5.1 slope = 0.64
Aimp 11.13 ± 4.9 L=0.5 s
Table 2: The mean critical artefact size ± standard deviation and the corresponding
parameters that generate it.
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